CalculatorGastroenterology and hepatology
MELD, MELD-Na and MELD 3.0 (age ≥ 12)
Estimates advanced liver disease severity and 90-day mortality with the three versions of the MELD model.
Updated 30 October 2026
When to use it
Patients aged 12 or over with cirrhosis or end-stage liver disease: liver transplant prioritisation, prognosis and assessment before TIPS or surgery.
What it needs
- Sex
- Total bilirubin
- Serum creatinine
- INR
- Serum sodium
- Serum albumin
- Dialysis ≥ 2 times in the past week or 24 h continuous haemofiltration
Formula
Bilirubin, INR and creatinine values < 1 are set to 1. Dialysis ≥ 2 times in the past week (or 24 h CVVHD) = maximum creatinine.
MELD = 9.57 × ln(Cr) + 3.78 × ln(Bil) + 11.2 × ln(INR) + 6.43 (Cr max 4)
MELD-Na = MELD + 1.32 × (137 − Na) − 0.033 × MELD × (137 − Na), only if MELD > 11 (Na 125–137)
MELD 3.0 = 1.33 (female) + 4.56 × ln(Bil) + 0.82 × (137 − Na) − 0.24 × (137 − Na) × ln(Bil) + 9.09 × ln(INR) + 11.14 × ln(Cr) + 1.85 × (3.5 − Alb) − 1.83 × (3.5 − Alb) × ln(Cr) + 6 (Cr max 3; Alb 1.5–3.5)
All are rounded to the nearest integer and capped at 40.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 9 | < 10: less advanced liver disease |
| 10–19 | 10–19: intermediate risk |
| 20–29 | 20–29: high risk |
| ≥ 30 | ≥ 30: very high risk |
In the app it also calculates: MELD-Na, MELD 3.0.
Practical tip
MELD 3.0 corrects the disadvantage of women (lower creatinine for the same renal function) and has been the OPTN allocation score in the USA since 2023.
3 more practical tips in the app.
Reference
- Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-470.
- Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91-96.
- Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018-1026.
- Kim WR, Mannalithara A, Heimbach JK, et al. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology. 2021;161(6):1887-1895.e4.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
